Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00650988 · ClinicalTrials.gov registry record · Early Phase 1
Cryotherapy for Barrett's Esophagus and Early Esophageal Cancers
A Early Phase 1 study, sponsored by Case Comprehensive Cancer Center.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 37
- Enrollment target
NCT00650988 is a Early Phase 1 study that has completed, run by Case Comprehensive Cancer Center. The registered enrollment target is 37 participants.
The verdict
NCT00650988, a Early Phase 1 study, has completed, sponsored by Case Comprehensive Cancer Center.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 37 participants
- Enrollment target
Study Summary
This is a single center study to evaluate the efficacy and safety of a new ablation technique involving the spray of liquid nitrogen through a catheter (cryotherapy) via an upper endoscopy (EGD) to ablate Barrett's esophagus with changes of high-grade dysplasia (HGD) or intramucosal cancer (IMCA) and patients with esophageal cancer limited to the esophageal wall, in whom there are no standard treatment options available.
Interventions
- PROCEDURE Cryospray Ablation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2005-09 |
| Est. Completion | 2008-12 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00650988
The ClinicalTrials.gov registry entry for NCT00650988 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 37 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Case Comprehensive Cancer Center, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Cryospray Ablation is the first listed.
NCT00650988 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00650988 about?
NCT00650988 is a clinical study titled "Cryotherapy for Barrett's Esophagus and Early Esophageal Cancers". This is a single center study to evaluate the efficacy and safety of a new ablation technique involving the spray of liquid nitrogen through a catheter (cryotherapy) via an upper endoscopy (EGD) to ablate Barrett's esophagus with changes of high-grade dysplasia (HGD) or intramucosal cancer (IMCA) an...
What is the current status of trial NCT00650988?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 37 participants. The study started on 2005-09. Estimated completion is 2008-12.
What interventions are being tested in trial NCT00650988?
The interventions under investigation include: Cryospray Ablation (PROCEDURE).
Who is sponsoring clinical trial NCT00650988?
This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.